Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Journal of Immune Based Therapies and Vaccines
|
December 24, 2010
Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B
Brian Drozdowski, Yuhong Zhou, Brad Kline, et al.
Oncotarget
|
September 2, 2015
Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature
Katherine Rybinski, Hongxia Z Imtiyaz, Barrie Mittica, et al.
Oncotarget
|
October 6, 2017
Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures
Niklas K Finnberg, Prashanth Gokare, Avital Lev, et al.
Cancer Immunity
|
March 10, 2007
Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha
Wolfgang Ebel, Eric L Routhier, Brian Foley, et al.
Molecular Cancer Therapeutics
|
September 29, 2018
MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity
Xin Cheng, Jing Li, Keigo Tanaka, et al.
Cancer Immunity
|
December 20, 2007
Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin
Raffit Hassan, Wolfgang Ebel, Eric L Routhier, et al.
Cancer Biology & Therapy
|
September 13, 2013
The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity
JianMin Lin, Jared L Spidel, Christopher J Maddage, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 2006
Human antibodies for immunotherapy development generated via a human B cell hybridoma technology
Jian Li, Tao Sai, Marc Berger, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Journal of Immune Based Therapies and Vaccines
|
December 24, 2010
Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B
Brian Drozdowski, Yuhong Zhou, Brad Kline, et al.
Oncotarget
|
September 2, 2015
Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature
Katherine Rybinski, Hongxia Z Imtiyaz, Barrie Mittica, et al.
Oncotarget
|
October 6, 2017
Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures
Niklas K Finnberg, Prashanth Gokare, Avital Lev, et al.
Cancer Immunity
|
March 10, 2007
Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha
Wolfgang Ebel, Eric L Routhier, Brian Foley, et al.
Molecular Cancer Therapeutics
|
September 29, 2018
MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity
Xin Cheng, Jing Li, Keigo Tanaka, et al.
Cancer Immunity
|
December 20, 2007
Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin
Raffit Hassan, Wolfgang Ebel, Eric L Routhier, et al.
Cancer Biology & Therapy
|
September 13, 2013
The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity
JianMin Lin, Jared L Spidel, Christopher J Maddage, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 2006
Human antibodies for immunotherapy development generated via a human B cell hybridoma technology
Jian Li, Tao Sai, Marc Berger, et al.
Page
of 4